Cryopreserved Chorionic Tissue in Maternal and Fetal Infection Therapy (Clinical and Experimental Research)
Keywords:
cryopreservation, chorionic tissue, maternal-fetal infectionAbstract
The cryosensitivity of chorionic tissue (CT) under different cryopreservation protocols, CT effect on pregnancy proceeding and outcome in laboratory animals were investigated. The application efficiency of preparation “Platex-chorionic†(PC) in a combined therapy of maternal-fetal infection (MFI) was under study. Both DMSO and that combined with PEO-4000 were shown to be the cryoprotectants of choice for CT freezing. Chorionic tissue has no teratogenic properties and positively affects the reproductive indices. The PC use in a combined therapy of MFI enables to improve placental structure, reduce the morbidity in gestation process and labor, thereby significantly enhancing prognosis for mother and newborn.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 V. Yu. Prokopyuk
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).